CliniCrowd
Community Testing and Validation of Nutriments
Company Overview
Snapshot
Founded in August 2016 by Michal Kahan, Ran Cohen, Irit (Friedman) Shefer, and Amir Sadeh, CliniCrowd operated with 1–10 employees. The company focused on leveraging crowdsourcing for clinical trials, particularly for nutriments, before ceasing operations in November 2021.
Business overview
CliniCrowd developed a platform to conduct crowd-sourced trials for nutriments, focusing on those often overlooked by the pharmaceutical industry due to lack of financial incentive. The company aimed to provide real-world evidence for scientifically-based solutions to prevent disease progression, utilizing artificial intelligence, machine learning, and big data analytics to collect and analyze patient data. CliniCrowd operated within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Pharma & Medical Biotechnology, serving patients and healthcare providers globally.
Strategic signal
In December 2021, research chronicled how CliniCrowd's crowdsourcing approach helped turn an orphan drug into a potential treatment for Parkinson's. This highlights the company's innovative model for validating therapeutic potential outside traditional pharmaceutical pathways, demonstrating the impact of its approach even after it ceased operations.
Log in to access full profile ›Company Intelligence Q&A
- What was CliniCrowd's primary focus?
- CliniCrowd focused on community testing and validation of nutriments, particularly those with therapeutic potential in animal models but lacking financial incentive for traditional randomized controlled trials.
- When was CliniCrowd founded?
- CliniCrowd was founded in August 2016.
- What technologies did CliniCrowd utilize?
- CliniCrowd utilized artificial intelligence, machine learning, and big data analytics to collect and analyze real-world patient data for insights into disease prevention and patient well-being.
- What was the operational status of CliniCrowd?
- CliniCrowd ceased to operate in November 2021.
- What was a notable outcome of CliniCrowd's crowdsourcing efforts?
- In December 2021, research highlighted how CliniCrowd's crowdsourcing model contributed to turning an orphan drug into a potential treatment for Parkinson's.